—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Stryker Corporation (SYK) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for SYK, from the same nightly bakes the boards use. Research diary readings, not advice.

Versus its index HALO Growth 100 — the name, its sleeve and the index over day, week and month

Versus its index

The name against its Closelooknet index and its own sleeve — equal-weight, nightly closes.

HALO Growth 100 · as of 2026-09-25

DayWeekMonth3 months
SYK+1.0%−1.0%−17.4%−18.1%
Surgical, Med Devices & Animal Health+0.2%+1.4%−3.7%—
HALO Growth 1000.0%+0.2%−7.6%—

Against the index: 1.2 pts behind on the week, 9.8 pts behind on the month; against its Surgical, Med Devices & Animal Health sleeve 13.7 pts behind on the month.

Returns from the index workers’ nightly closes; equal-weight sleeves. A relative reading from the research diary, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sector × region Health care in US: +1.8% week · −1.3% month · +6.9% quarter · +12.8% yearThe Sector Engine cell this name lives in, from XLV.US; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-09-26
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
How it trades on rate days beta 0.49 to TLT · on the worst bond days it fell more than the market

How it trades on rate days

How SYK has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.49 — tends to move with bonds for every 1% move in TLT (20+ year Treasuries), Stryker Corporation moved 0.49% on average · correlation 0.15 · higher than 51% of US names
  • Beta, last 3 months 0.69 about the same as over the year
  • On the 10 worst bond days −1.20% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days −1.34% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against HALO Growth 100 · Surgical, Med Devices & Animal Health · 7 names with week and year-to-date

Peer group

HALO Growth 100 · Surgical, Med Devices & Animal Health

Robotic surgery, continuous-glucose sensors, cochlear implants, animal-health platforms. Regulated moats, multi-decade compounders.

Compared against SYK on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Stryker Corporation

SYK in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Stryker Corporation makes medical technology sold to hospitals and clinics, organised into two areas. MedSurg and Neurotechnology covers surgical tools, patient-safety systems, navigation equipment, endoscopy, emergency and intensive-care products, and devices for treating stroke. Orthopaedics supplies implants for joint replacement and trauma surgery, including its Mako robotic-assisted surgery system. It sells through its own subsidiaries and through outside distributors across many countries, and is based in Portage, Michigan.
Where it sits in the stack
Stryker sits in our HALO Growth 100, the growth index we track outside the megacaps, within the Surgical, Med Devices & Animal Health sleeve. It carries no seat in the Rubin AI build-out index; its business runs on hospital capital budgets and device reimbursement rather than on chip or data-centre demand.
Who it is priced against
Closelooknet's peer group for this sleeve gathers regulated, multi-decade device compounders: Globus Medical, IDEXX Laboratories, Intuitive Surgical, Sonova, Sartorius and the glucose-monitoring pair DexCom and Insulet. The market also names Medtronic as a direct comparison.
Why Closelooknet tracks it
Stryker holds a seat in the HALO Growth 100 and carries a Closelooknet score built from seven modules, with quality reading as the strongest module and momentum as the weakest. The diary has not yet logged a quote or a mention for the name.
What the diary watches
The diary watches whether momentum turns as the chart closes its distance from the longer-term average, since that would rebalance the composite away from its current quality-led reading.

Stryker Corporation (SYK) trades on US exchanges, classified under Healthcare. Constituent of HALO Growth 100.

The Closelooknet company score reads 51/100 composite (momentum 17, quality 65, valuation 46) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: SYK news on the tape · index compare · sector dispersion · scanner.

The Street on this name 1 analyst action on the wire · latest: price target by Canaccord, 2026-09-18

The Street on this name

Analyst actions and the latest print for SYK from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Price target Canaccord — target 385 from 400 Target cut to $385 from $400 (+37.4% to spot) 2026-09-18

1 action on the analyst wire since 2026-08-13: 1 target change. Analyst wire → · Earnings wire →

Dividends and capital return trailing yield 1.28%, quarterly · buybacks 149 m USD in FY2025

Dividends and capital return

What SYK pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 3.48 USD per share · a 1.28% yield on the 2026-09-25 close 4 distributions, paid quarterly 2026-09-25
  • Change on the year +4.8% against the prior twelve months prior twelve months 3.32 USD per share
  • Last distribution 0.88 USD per share as the price series records it, within days of the ex-date 2026-06-30
  • By calendar year 2023: 1.55 USD (partial) · 2024: 3.24 USD · 2025: 3.40 USD · 2026: 1.76 USD to date first distribution recorded in the three-year window: 2023-09-28
  • Dividends paid, FY2025 1.28 bn USD 25% of earnings
  • Buybacks, FY2025 149 m USD 0.1% of today's market value
  • Share count −0.9% in FY2025 243 m USD of stock-based compensation in the year
  • Capital returned 1.43 bn USD · 33% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-09-26

Quick answers

What is Stryker Corporation (SYK)?

Stryker Corporation trades as SYK on the US exchange (US) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is SYK in a Closelooknet index?

Yes — Stryker Corporation is a constituent of HALO Growth 100, as of 2026-09-26.

What is Stryker Corporation's Closelooknet composite score?

51 out of 100, with momentum 17, quality 65 and valuation 46 sub-scores, as of 2026-09-26. Scores are Closelooknet's own research readings, not ratings or investment advice.

Where does SYK trade against its moving averages?

New 52-week low: At a fresh 52-week low — the weakest it has been in a year. As of 2026-09-24 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How is SYK doing against its Closelooknet index?

Over the past month Stryker Corporation is −17.4% against −7.6% for the HALO Growth 100 — 9.8 points behind its index, as of 2026-09-25. Its Surgical, Med Devices & Animal Health sleeve is −3.7% over the same month. The “Versus its index” table on this page carries the day, the week and the month for the name, its sleeve and the index.

How does Stryker Corporation trade when bond yields rise?

Over the past year Stryker Corporation had a beta of 0.49 to TLT, the long-dated Treasury fund — it tends to move with bonds, higher than 51% of US names. On the 10 sessions in which long bonds fell most it moved −1.20% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does Stryker Corporation do?

Stryker Corporation makes medical technology sold to hospitals and clinics, organised into two areas. MedSurg and Neurotechnology covers surgical tools, patient-safety systems, navigation equipment, endoscopy, emergency and intensive-care products, and devices for treating stroke. Orthopaedics supplies implants for joint replacement and trauma surgery, including its Mako robotic-assisted surgery system. Closelooknet's peer group for this sleeve gathers regulated, multi-decade device compounders: Globus Medical, IDEXX Laboratories, Intuitive Surgical, Sonova, Sartorius and the glucose-monitoring pair DexCom and Insulet. The market also names Medtronic as a direct comparison.

Where does Stryker Corporation sit in the AI build-out?

Stryker sits in our HALO Growth 100, the growth index we track outside the megacaps, within the Surgical, Med Devices & Animal Health sleeve. It carries no seat in the Rubin AI build-out index; its business runs on hospital capital budgets and device reimbursement rather than on chip or data-centre demand. Stryker holds a seat in the HALO Growth 100 and carries a Closelooknet score built from seven modules, with quality reading as the strongest module and momentum as the weakest. The diary has not yet logged a quote or a mention for the name.

Does Stryker Corporation pay a dividend?

Stryker Corporation has paid 3.48 USD per share over the last twelve months, paid quarterly, a trailing yield of 1.28% on the 2026-09-25 close; the last distribution recorded in the price series was 0.88 USD on 2026-06-30. In fiscal 2025 the company paid 1.28 bn USD in dividends and bought back 149 m USD of its own shares, 33% of that year’s free cash flow. The share count fell 0.9% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

What has Wall Street done on Stryker Corporation recently?

The most recent analyst action on Stryker Corporation on the Closelooknet wire is a price target by Canaccord on 2026-09-18 (target 385 from 400). 1 action on the analyst wire since 2026-08-13: 1 target change. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for SYK, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

same Closelooknet index seat first, then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.